Feed Komunita
BC
Bill Combs
@billcombs · 25. 5.

Hey, investors.

I've been interested in the healthcare sector quite a bit lately. Because I see a lot of potential in it.

Medicine in general has made huge strides recently, whether it's the production of weight loss drugs, for example, or the production of robots for surgery.

I have $JNJ and $CVS in my portfolio so far, but I'm still thinking about $MDT, which is the company that makes the robots for surgery.

How do you look at this sector and do you have any stocks from this sector in your portfolio?

Osobní pohled člena komunity, ne investiční doporučení. Pravidla komunity

RR
Rickie Reeve @rickiereeve 25. 5.

I have $CVS and I'm still watching $PFE. Exceedingly good prices, I'd say. 😁

BC
Bill Combs @billcombs 26. 5.

I agree, $PFE is at a really nice price point.

DD
Daniela Duong @danieladuong 25. 5.
BC
Bill Combs @billcombs 25. 5.

Yeah, that's for sure😁

JB
Jason Bellier @neostonks 25. 5.

I don't follow Medtronic, so I can't give you much advice here. For myself, I like JNJ, CVS and LLY.

BC
Bill Combs @billcombs 25. 5.

I'm not familiar with LLY, but I will definitely check this company out.

Thank you for the tip

CB
Clifford Barclay @cliffordbarclay 25. 5.

In the long run, I'm still considering Moderna or Pfizer basically based on this article. It says they have a significant scientific lead that will be apparent by the end of the decade

https://www.theguardian.com/society/2023/apr/07/cancer-and-heart-disease-vaccines-ready-by-end-of-the-decade

BC
Bill Combs @billcombs 25. 5.

I've been thinking about these companies too. I personally like Pfizer $PFE better.

Thank you for the link

AA
Ashraf Aboudar @ashraf_dd 25. 5.

I have$CVS in my portfolio, it's a great company. I don't study the others in detail, but the future is promising in this sector.

BC
Bill Combs @billcombs 25. 5.

I have$CVS in my portfolio as well and I agree with you. It's a great company.

Používáme nezbytné cookies pro fungování webu a volitelné analytické cookies pro měření návštěvnosti. Více v Zásadách ochrany osobních údajů.